drugset / Trial / NCT04621227
Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With Obesity
NaCrossoverOpen-labelOther
Summary
A Phase 1 Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With Obesity
Timeline
- Start
- 2020-12-15
- Primary completion
- 2021-05-13
- Completion
- 2021-05-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Danuglipron | Small molecule | 120 mg | — |
| Subject | Danuglipron | Small molecule | 200 mg | — |
| Subject | Midazolam | Small molecule | 2 mg | Oral |
| Subject | Rosuvastatin | Small molecule | 10 mg | Oral |